Chronic treatments with a 5-HT4 receptor agonist decrease amyloid pathology in the entorhinal cortex and learning and memory deficits in the 5xFAD mouse model of Alzheimer's disease
Keywords: پیچ و خم لوله های پیچ و خم; 5-HT4 receptor agonist; Alzheimer's disease; Memory impairments; Olfactory tubing maze; Transgenic mouse model; Pharmacotherapy; 5-HT4R; 5-Hydroxytryptamine type 4 receptor; Aβ; Amyloid beta peptide; AD; Alzheimer's Disease; ApoE; Apolipoprotein E; APP;